Skip to main content

Iatrogenic Lung Diseases

  • Chapter
  • First Online:
Pathology of Lung Disease
  • 3028 Accesses

Abstract

Drug-induced interstitial lung diseases present with a variety of tissue reaction, most of them already discussed in previous chapters. A common presentation is diffuse alveolar damage as an acute reaction, often followed by organizing DAD, where hyaline membranes can still be recognized, and finally ending as organizing pneumonia and lung fibrosis. Other drugs induce NSIP-like tissue reactions. The major problem in interpreting drug reaction in the lung is our limited understanding of drug metabolism. Some drugs will induce toxic injury of endothelial cells, thus the blood barrier is leaking, and proteins can enter the interstitium and finally the alveolar lumen. Here these proteins will form complexes and by the action of respiration hyaline membranes will form. In addition the exudate from the capillaries will cause a transient edema and this is followed by hypoxia affecting the pneumocytes. This damage will contribute to DAD development (Fig. 14.1). Later on organizing pneumonia can result. Other drugs act on the immune system, forming immune complexes either because they are immunogenic by themselves or by complexing with endogenous proteins like a hapten. In these cases a NSIP or LIP pattern can result. In these cases scattered eosinophils are regularly found. Rarely granulomas are formed, usually pointing to an underlying immune mechanism. Since our understanding is so limited and no systematic experimental investigation has been performed, we still need to rely on databases, summarizing all described drug reactions in a systematic way (www.pneumotox.com; [1–8]).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beinert T, Binder D, Stuschke M, Jorres RA, Oehm C, Fleischhacker M, Sezer O, Mergenthaler HG, Werner T, Possinger K. Oxidant-induced lung injury in anticancer therapy. Eur J Med Res. 1999;4:43–53.

    CAS  PubMed  Google Scholar 

  2. Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, Chan K, Karlsson A, Lin C, Taff A, West J, Fanucchi M, Van Winkle L, Plopper C. Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev. 2002;34:791–820.

    Article  CAS  PubMed  Google Scholar 

  3. Cohen GM. Pulmonary metabolism of foreign compounds: its role in metabolic activation. Environ Health Perspect. 1990;85:31–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Dinsdale D. Lung injury: cell-specific bioactivation/deactivation of circulating pneumotoxins. Int J Exp Pathol. 1995;76:393–401.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Garrido M, O’Brien A, Gonzalez S, Clavero JM, Orellana E. Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Chest. 2007;132:1997–9.

    Article  PubMed  Google Scholar 

  6. Gupta S, Mahipal A. Fatal pulmonary toxicity after a single dose of cyclophosphamide. Pharmacotherapy. 2007;27:616–8.

    Article  CAS  PubMed  Google Scholar 

  7. Kameda H, Okuyama A, Tamaru J, Itoyama S, Iizuka A, Takeuchi T. Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol. 2007;26:1585–9.

    Article  PubMed  Google Scholar 

  8. Myers J, El-Zammar O. Pathology of drug-induced lung disease; In: Katzenstein AL. Surgical pathology of non-neoplastic lung disease. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: Saunders Elsevier; 2006. pp 81–111.

    Google Scholar 

  9. Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol. 2005;44:13–22.

    Article  PubMed  Google Scholar 

  10. Downing L, Sawarynski KE, Li J, McGonagle M, Sims MD, Marples B. A simple quantitative method for assessing pulmonary damage after x irradiation. Radiat Res. 2010;173:536–44.

    Article  CAS  PubMed  Google Scholar 

  11. Faruqi S, Giuliani ME, Raziee H, Yap ML, Roberts H, Le LW, Brade A, Cho J, Sun A, Bezjak A, Hope AJ. Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2014;89:1076–83.

    Article  PubMed  Google Scholar 

  12. Crestani B, Kambouchner M, Soler P, Crequit J, Brauner M, Battesti JP, Valeyre D. Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma. Eur Respir J. 1995;8:318–21.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Popper, H. (2017). Iatrogenic Lung Diseases. In: Pathology of Lung Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50491-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50491-8_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50489-5

  • Online ISBN: 978-3-662-50491-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics